[HTML][HTML] A review of environmental metabolism disrupting chemicals and effect biomarkers associating disease risks: Where exposomics meets metabolomics

J Sun, R Fang, H Wang, DX Xu, J Yang, X Huang… - Environment …, 2022 - Elsevier
Humans are exposed to an ever-increasing number of environmental toxicants, some of
which have gradually been elucidated to be important risk factors for metabolic diseases …

Toxicity testing in the 21st century: progress in the past decade and future perspectives

D Krewski, ME Andersen, MG Tyshenko… - Archives of …, 2020 - Springer
Advances in the biological sciences have led to an ongoing paradigm shift in toxicity testing
based on expanded application of high-throughput in vitro screening and in silico methods …

Systems toxicology: from basic research to risk assessment

SJ Sturla, AR Boobis, RE FitzGerald… - Chemical research in …, 2014 - ACS Publications
Systems Toxicology is the integration of classical toxicology with quantitative analysis of
large networks of molecular and functional changes occurring across multiple levels of …

Promises and challenges of big data computing in health sciences

T Huang, L Lan, X Fang, P An, J Min, F Wang - Big Data Research, 2015 - Elsevier
With the development of smart devices and cloud computing, more and more public health
data can be collected from various sources and can be analyzed in an unprecedented way …

[HTML][HTML] t4 workshop report: State-of-the-art of 3D cultures (organs-on-a-chip) in safety testing and pathophysiology

N Alépée, A Bahinski, M Daneshian, B De Wever… - Altex, 2014 - ncbi.nlm.nih.gov
Integrated approaches using different in vitro methods in combination with bioinformatics
can (i) increase the success rate and speed of drug development;(ii) improve the accuracy of …

[HTML][HTML] “Omics”-informed drug and biomarker discovery: opportunities, challenges and future perspectives

H Matthews, J Hanison, N Nirmalan - Proteomes, 2016 - mdpi.com
The pharmaceutical industry faces unsustainable program failure despite significant
increases in investment. Dwindling discovery pipelines, rapidly expanding R&D budgets …

[HTML][HTML] The toxicity of nanoparticles and their interaction with cells: an in vitro metabolomic perspective

M Awashra, P Młynarz - Nanoscale Advances, 2023 - pubs.rsc.org
Nowadays, nanomaterials (NMs) are widely present in daily life due to their significant
benefits, as demonstrated by their application in many fields such as biomedicine …

[HTML][HTML] Use cases, best practice and reporting standards for metabolomics in regulatory toxicology

MR Viant, TMD Ebbels, RD Beger, DR Ekman… - Nature …, 2019 - nature.com
Metabolomics is a widely used technology in academic research, yet its application to
regulatory science has been limited. The most commonly cited barrier to its translation is …

[HTML][HTML] Prediction of liver toxicity and mode of action using metabolomics in vitro in HepG2 cells

T Ramirez, A Strigun, A Verlohner, HA Huener… - Archives of …, 2018 - Springer
Liver toxicity is a leading systemic toxicity of drugs and chemicals demanding more human-
relevant, high throughput, cost effective in vitro solutions. In addition to contributing to animal …

Good cell culture practice for stem cells and stem-cell-derived models

D Pamies, A Bal-Price, A Simeonov, D Tagle, D Allen… - 2017 - kops.uni-konstanz.de
The first guidance on Good Cell Culture Practice dates back to 2005. This document
expands this to aspects of quality assurance for in vitro cell culture focusing on the …